EDGAR Filing Documents for 0001654954-18-000151

Form 8-K - Current report:

SEC Accession No. 0001654954-18-000151

Filing Date

2018-01-05

Accepted

2018-01-05 17:05:04

Documents

Period of Report

2017-12-31

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	azrx8k_dec312017.htm	8-K	39015
2	FORM OF EXERCISE LETTER	ex10-1.htm	EX-10.1	36378
3	FORM OF PARTIAL EXERCISE LETTER	ex10-2.htm	EX-10.2	45588
4	IMAGE	azrxlogo.jpg	GRAPHIC	8115
	Complete submission text file	0001654954-18-000151.txt		133561

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226

Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855

AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 18514102
SIC: 2834 Pharmaceutical Preparations